Geron halting embryonic stem cell research, laying off staff

News from The Associated Press: The company doing the first government-approved test of embryonic stem cell therapy is discontinuing further stem cell work, a move with stark implications for a field offering hope of future medicines for conditions with inadequate or no current treatments.